Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+105.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+105.5%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
8.7x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 30.13% |
| 2023 | -647.61% |
| 2022 | 141.43% |
| 2021 | 3.47% |
| 2020 | -0.72% |
| 2019 | -4.33% |
| 2018 | 4.56% |
| 2017 | -3.68% |
| 2016 | -12.11% |
| 2015 | -29.24% |